2 results in 0.0031 seconds.
-
US becomes first country in the world to approve breakthrough Alzheimer's drug lecanemab that slows symptoms by 27% and costs $27,000 a year.
That's great news. Now, if they could only find a cure for cancer. Or diabetes. -
Breakthrough Alzheimer's drug may mark the 'beginning of the end' in decades-long search for treatment to halt cruel memory decline.
Now, this is good news.